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Objective: The objective of this study was to evaluate long-term outcome of renal revascularization by ex vivo renal artery
reconstruction for complex renal artery disease.
Methods: From 1987 to 2012, 23 patients (17 women; mean age, 45 years) with complex renal artery lesions underwent
open renal revascularization by ex vivo technique.Underlying disease included ﬁbromuscular dysplasia with aneurysm (11),
atherosclerotic aneurysm (6), Takayasu arteritis (3), and other (3). Outcomes analyzed included primary, primary assisted,
and secondary patency rates; antihypertensivemedication requirements; renal function and preservation; andmortality. Late
graft patency, renal size, and cortical thickness were analyzed by serial renal duplex ultrasound examinations.
Results: Twenty-four kidneys in 23 patients were revascularized by ex vivo renal artery reconstructive techniques. Periop-
erative complications were limited to two patients requiring reoperation for bleeding. Renal function did not change, and
there were no in-hospital deaths. During a mean follow-up of 44 months, a single bypass graft occluded, requiring repeated
bypass, which was performed with renal preservation. Primary, primary assisted, and secondary patency rates were 94% at 5
and 10 years. Compared with preoperative values, systolic and diastolic blood pressure and the number of antihypertensive
medications were reduced (P < .05) in the 18 patients with hypertension. Late renal function was preserved as measured by
no change in both serum creatinine concentration and estimated glomerular ﬁltration rate compared with preintervention
values (P [ .25 and P [ .35, respectively). In addition, there was no difference in treated kidney size or renal cortical
thickness on follow-up compared with preoperative measurements (P[ .15 and P[ .62, respectively). No patient required
dialysis. There were three late deaths, none related to the renal procedure, providing 5- and 10-year survival of 85% and 68%,
respectively.
Conclusions: Ex vivo renal artery reconstruction for complex renal artery disease confers a beneﬁt in blood pressure while
preserving renal mass and function. This technique should be considered a competitive alternative to other open surgical
techniques for the management of complex renal artery disease. (J Vasc Surg 2014;60:143-51.)Management of complex renal artery disease involving
the distal renal artery, segmental branch vessels, or renal hilum
is a surgical challenge. Disease may be in the form of aneu-
rysm, occlusive disease, dissection, or mass due to a variety
of causes including atherosclerosis, medial ﬁbrodysplasia,
arteritis, arteriovenous ﬁstulas, and tumor. During the past
four decades, numerous techniques for renal salvage in the
treatment of complex renal artery disease have been
reported.1-7 Kidneys with disease involving segmental branch
vessels that were once threatened by nephrectomy have
been successfully treatedwith amyriad of reconstructive tech-
niques and adjuncts, such as hypothermic renal protection.
Many modiﬁcations have been made to the original
description of ex situ renal artery reconstruction by Ota in
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orthotopic or heterotopic autotransplantation of the repaired
kidney.Therehave evenbeenhybrid approaches, such as lapa-
roscopic nephrectomy with ex vivo bench repair and pelvic
autotransplantation, to address complex lesions.9 Further-
more, as percutaneous techniques have evolved, catheter-
based interventions with coils and stents have increasingly
been used to primarily treat complex renal artery lesions.
A number of studies have demonstrated the safety,
durability, and clinical beneﬁts on blood pressure and renal
function of open reconstructive and renal parenchymal pro-
tective techniques in the treatment of complex renal artery
disease.1-5,7 Many of these reports come from select centers
with a focused interest in the management of renal artery
disease. However, long-term data regarding preservation
of renal function and mass in surgically treated patients
with complex renal artery lesions are lacking. Speciﬁcally,
there are limited anatomic data in regard to the change
in renal morphology (kidney length, cortical thickness) af-
ter surgical revascularization. In this report, our institu-
tional experience during a 25-year period using ex vivo
techniques for complex renal artery disease is reviewed
with a speciﬁc emphasis on long-term blood pressure, renal
function, renal mass, graft patency, and patient survival.
METHODS
Patient population. From 1987 to 2012, all patients
who underwent renal revascularization for complex renal
artery disease by ex vivo reconstructive techniques at the143
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(USC) and Los Angeles County and USC Medical Center
were identiﬁed. Renal artery lesions were considered com-
plex if disease included the distal renal artery with contin-
uous extension to the ﬁrst branch or renal hilum and when
primary, secondary, or tertiary branch involvement was
present. Examples of segmental branch involvement
included aneurysms originating from a major branch point,
saccular aneurysm of a branch vessel, and branch occlusive
disease. Despite advances in endovascular techniques in the
later part of our series, including more precise emboliza-
tion delivery and the availability of smaller covered stents,
we preferentially treated patients with complex renal artery
disease by the ex vivo technique because endovascular
therapy would require compromising segmental vessels to
achieve technical success. The underlying etiology of com-
plex lesions included nonatherosclerotic renal artery dis-
ease, such as ﬁbromuscular dysplasia (FMD), Takayasu
arteritis (TA), and dissection, as well as atherosclerotic
degenerative lesions. The types of lesions treated included
aneurysm with or without arteriovenous ﬁstulas, dissection,
renal artery stenosis, and malignant neoplasm. The diag-
nosis of FMD was based on characteristic preoperative
angiographic ﬁndings, and in the absence of the typical
“string of beads” appearance on angiography, the diag-
nosis of FMD was excluded. All patients with TA met diag-
nostic criteria according to the American College of
Rheumatology. Hospital charts, imaging studies, and
outpatient records of all patients were reviewed with the
approval of the USC Health Sciences Institutional Review
Board.
Information collected included patient demographic
data, such as race, age, and gender. Clinical data included
comorbidities; baseline blood pressure; number of antihy-
pertensive medications; renal size in length measured
pole to pole and cortical thickness over a medullary pyr-
amid, perpendicular to the capsule in the sagittal plane
by renal ultrasound duplex examination; serum creatinine
(SCr) concentration; computed tomography (CT) and
angiographic ﬁndings; and all procedures performed
with associated 30-day or in-hospital morbidity and mor-
tality as well as late survival. Graft surveillance was
assessed by periodic ultrasound duplex examination,
CT, angiography, or magnetic resonance angiography.
Hypertension was deﬁned as systolic blood pressure
greater than 140 mm Hg or diastolic blood pressure
greater than 90 mm Hg or preoperative use of one or
more antihypertensive medications. Renal function was
determined with SCr concentration and estimated
glomerular ﬁltration rate (eGFR) by the Cockcroft-
Gault method. Renal dysfunction was deﬁned as SCr level
of 1.5 mg/dL or greater.
Measured outcomes. End points included the com-
parison of preoperative blood pressure and antihyperten-
sive medication requirements, eGFR, SCr level, renal
length, and cortical thickness with those at follow-up;
long-term patency rates of renal revascularization; and
survival. Cure from hypertension was deﬁned as bloodpressure below 140/90 mm Hg and requiring no blood
pressure medications. Clinical improvement was deﬁned as
systolic blood pressure below 140 mm Hg or diastolic
blood pressure below 90 mm Hg on the same number of
blood pressure medications or a reduction of diastolic
blood pressure by 15 mm Hg or more while taking the
same or a fewer number of blood pressure medications.
Unchanged blood pressure with a reduction in medication
number was considered a clinical improvement. Response
was considered to be not improved if criteria for cure or
improvement were not fulﬁlled.10 The Social Security
Death Index was used to investigate mortality for patients
lost to follow-up.
Imaging studies. All patients underwent preoperative
abdominal aortography. Aortography included the abdom-
inal aorta and selective renal artery catheterization to char-
acterize the lesions and for operative planning. CT scans
with intravenous administration of contrast material were
selectively performed to clarify aneurysm extent and arte-
riovenous ﬁstulas when present. Duplex ultrasonography
was routinely performed intraoperatively at the time of
revascularization to assess the technical proﬁciency of all re-
constructions. If abnormalities were detected, revision of
the reconstruction was performed at the operating sur-
geon’s discretion. Patency of revascularizations was
assessed by serial duplex ultrasonography at 1 and 6 months
after intervention, then annually thereafter. CT angiog-
raphy, magnetic resonance angiography, or angiography
was used adjunctively as needed. Angiography was per-
formed to conﬁrm stenosis or occlusion when noninvasive
imaging detected renal artery restenosis or graft stenosis or
occlusion. A loss in renal mass alone was not a speciﬁc cri-
terion used for more invasive testing.
Surgical technique. General aspects of ex vivo renal
artery repair have been described elsewhere.1,2,5,11,12 We
preferentially perform ex vivo renal exposure and vascular
reconstruction with orthotopic replacement. A subcostal
incision is used for unilateral renal artery exposure. A
midline transperitoneal approach is reserved for patients
who require a more extensive exposure to facilitate repair.
The preferred conduit is autogenous saphenous vein.
Prosthetic material is used when no suitable vein is avail-
able. Operations are staged for bilateral revascularizations
(Fig 1).
The main renal artery and vein and infrarenal aorta are
dissected and controlled. All segmental branch vessels are
identiﬁed and individually controlled as well. The ureter
is left intact and mobilized sufﬁciently to allow elevation
of the kidney to the level of the abdominal wall. Once
the kidney is mobilized from the renal fossa and systemic
heparin is given, the renal vein is divided with a cuff of
vena cava and the proximal renal artery is divided and
ligated at the stump (Figs 2 and 3). We preferentially
employ ex vivo repair with renal vein division to address
all disease involving the terminal renal artery with
segmental branch involvement over alternative techniques,
such as in situ repair or total renal mobilization without
renal vein transection with cold perfusion.
Fig 1. Exposure of the right kidney and renal vascular pedicle. IVC, Inferior vena cava. (Reprinted with permission
from Hood DB, Weaver FA. Orthotopic ex vivo renal artery reconstruction. Am Surg 1994;60:804-8.)
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parenchymal hypothermia is established through external
and internal parenchymal cooling techniques. For internal
parenchymal hypothermia, approximately 500 mL of Uni-
versity of Wisconsin (UW) solution chilled to 4C is
ﬂushed through the renal artery until the efﬂuent of the
renal vein runs clear. Collins solution modiﬁed with the
addition of heparin 2000 units and 50 mL of 10% dextrose
was used in the earlier part of the series before UW solution
became commercially available. For external renal cooling,
the kidney is brought out of the renal fossa with the ureter
still intact to the level of the abdominal incision, placed in a
sterile bag of ice slush, and covered with chilled laparotomy
pads. To maintain surface hypothermia, cold saline is
continuously irrigated onto the surface of the kidney. A
soft jaw noncrushing clamp is placed on the ureter to pre-
vent premature warming of the kidney from retrograde
periureteral collaterals. At this point, complex renal artery
lesions at the hilum are explored and reconstructed in a
bloodless ﬁeld.
Reconstructive techniques. Reconstructive technique
varies according to the type and extent of the renal artery
lesion. For aneurysmal disease with direct branch vessel
involvement, aneurysm resection is followed by branch
repair. For aneurysms with a ﬁstulous communication to
the renal vein, resection of both aneurysm and ﬁstula is fol-
lowed by branch repair and primary repair of the renal vein.
In most cases, branch repair involved the joining ofmultiple segmental vessels at their origin, creating a com-
mon patch that is used for the distal anastomosis. Individ-
ual branch vessels that cannot be combined are reimplanted
individually on the bypass graft (Fig 4).
Once branch reconstruction and the distal anastomosis
are completed, the kidney is placed back into the renal
fossa. The proximal graft to infrarenal aorta anastomosis
is performed ﬁrst, followed by the renal vein anastomosis
to the vena cava. At completion, an intraoperative renal
duplex examination is performed. Once hemostasis is
ensured, Gerota fascia is reapproximated to prevent renal
torsion (Fig 5).
Statistical analysis. All appropriate variables were
analyzed for normality before descriptive statistics were
applied. Continuous variables were summarized as
mean 6 standard deviation and compared by two-tailed
t-tests. Categorical variables were expressed as frequency
and percentage. Survival was estimated by the life-table
method. P < .05 was considered statistically signiﬁcant.
Statistical analysis was performed with SPSS version 17.0
(SPSS Inc, Chicago, Ill).
RESULTS
Twenty-four kidneys were revascularized by ex vivo
repair in 23 patients. One patient underwent staged bilat-
eral renal revascularization for bilateral renal aneurysms.
The majority of patients were women 17 (74%). Most pa-
tients were relatively young (mean age, 45 years). Eighteen
Fig 3. Intraoperative photograph of a left renal artery aneurysm
with segmental branch vessel involvement. All segmental branch
vessels are individually controlled with Silastic loops.
Fig 4. Intraoperative photograph of an ex vivo renal artery
aneurysm repair. Aneurysm repair and branch reconstruction are
performed ﬁrst.
Fig 2. The ex vivo right kidney under hypothermic cold preserva-
tion. Right renal artery and vein (RV) transected. Note the Fogarty
soft jaw clamp placed on the ureter to prevent rewarming of the
kidney during cold perfusion. IVC, Inferior vena cava. (Reprinted
with permission from Hood DB, Weaver FA. Orthotopic ex vivo
renal artery reconstruction. Am Surg 1994;60:804-8.)
Fig 5. Illustration of a right renal artery aneurysm repair at
completion with the kidney replaced in its orthotopic position.
IVC, Inferior vena cava; RV, renal vein. (Reprinted with permis-
sion from Hood DB, Weaver FA. Orthotopic ex vivo renal artery
reconstruction. Am Surg 1994;60:804-8.)
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were dialysis dependent (Table I). Indications for surgery
included aneurysm, abdominal or ﬂank pain, and renovas-
cular hypertension.
Underlying disease included FMD (12), atheroscle-
rotic aneurysm (6), TA (3), dissection (2), and renal carci-
noma (1). Overall, 19 repairs (79%) were performed foraneurysmal disease (Table II). Two patients with TA had
renal artery stenosis with branch occlusive disease, and
the third patient with TA had aneurysmal degeneration
of the distal renal artery requiring ex vivo repair. Two pa-
tients who had new-onset hypertension had an occluded
main renal artery from dissection with reconstitution of
the segmental branch vessels and underwent successful
ex vivo revascularization. One patient with a solitary kidney
harboring transitional cell carcinoma near the hilum
required ex vivo exposure for an oncologic resection. Par-
tial nephrectomy followed by saphenous vein renal bypass
was successfully performed jointly with a urologist in a
bloodless ﬁeld.
Table III summarizes procedure details. All 24 kidneys
underwent successful ex vivo aorta-renal revascularization
Table I. Demographic and patient characteristics
Characteristics No. (%)
Total number of patients 23
Women 17 (74)
Age in years, mean 6 SD 45 6 15
Diabetes mellitus 2 (8.7)
Tobacco (history or current) 4 (17)
CAD or MI 0
CHF 1 (4.3)
Hypertension 18 (78)
COPD 0
Renal insufﬁciencya 5 (22)
Dialysis dependent 0
Follow-up, months
Mean 6 SD 44.4 6 53.8
Median 29.7
Range 0.2-193
CAD, Coronary artery disease; CHF, congestive heart failure; COPD,
chronic obstructive pulmonary disease; MI, myocardial infarction; SD,
standard deviation.
aSerum creatinine concentration $ 1.5 mg/dL.
Table II. Renal artery disease
No. of kidneys
N ¼ 24 (%)
FMD 12 (50)
Aneurysm 12
Atherosclerotic aneurysm 6 (25)
TA 3 (12.5)
Branch occlusive 2
Aneurysm 1
Other 3 (12.5)
Dissection 2
Renal cell cancera 1
FMD, Fibromuscular dysplasia; TA, Takayasu arteritis.
aSolitary kidney.
Table III. Procedure details
No. of kidneys
N ¼ 24 (%)
Ex vivo repair with orthotopic placement
into renal fossa
24 (100)
Branch repair with saphenous vein graft 21 (88)
Branch repair with cephalic vein graft 1 (4)
Branch repair with reimplantation 1 (4)
Partial nephrectomy, saphenous vein grafta 1 (4)
aSolitary kidney.
Fig 6. Patency curve by life-table methods for all interventions.
Primary, primary assisted, and secondary patency are shown.
Standard error is >10% indicated by standard error bars. Standard
error is <10% for all other data points.
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two repairs used reversed saphenous vein as conduit.
Reversed cephalic vein was used in one patient with a his-
tory of bilateral great saphenous vein ablations. In another
patient with an 8-cm renal artery aneurysm and an associ-
ated ﬁstulous connection to the renal vein, aneurysm and
ﬁstula resection and primary arterial repair with direct im-
plantation of the renal artery to the aorta were possible.
There was one intraoperative ureteral thermal injuryrequiring segmental resection and primary anastomosis.
No nephrectomies were performed for either primary or
remedial procedures. There were no operative deaths.
Three complications occurred in three patients in the
30-day or in-hospital period. Two patients were taken
back to the operating room for bleeding within 24 hours
of the procedure. One patient was found to have bleeding
from an unrecognized splenic capsular tear, which was
managed without the need for splenectomy. In the other
patient, bleeding from the oversewn renal artery stump
was recognized and repaired. The remaining hospital
course was unremarkable for both patients. One patient
with preexisting renal insufﬁciency developed acute tubular
necrosis resulting in nonoliguric renal failure, which
resolved without the need for dialysis. There was no renal
artery or graft occlusion in the perioperative period. There
were no operative deaths.
During a mean follow-up of 44 months, one bypass
graft developed stenosis at 8 months. This occurred in a pa-
tient in whom reversed cephalic vein was used as the graft
conduit. Eight months later, she developed hypertension,
and bypass graft stenosis was detected on renal duplex ul-
trasonography. She underwent renal bypass graft angio-
plasty and stenting; however, the patient returned
1 month later with recurrent hypertension and an occluded
graft. The patient successfully underwent repeated in situ
iliac to renal bypass with prosthetic material. Overall, pri-
mary, primary assisted, and secondary graft patency rate
was 94% at 5 and 10 years (Fig 6).
Revascularization reduced mean blood pressure for all
18 patients with hypertension, 166 6 22/100 6 21 to
133 6 16/81 6 12 mm Hg (P ¼ .002), and the number
of antihypertensive medications, 2.3 6 1.2 to 1.2 6 1
drugs per patient (P ¼ .001). Overall, 17 patients (94%)
were either cured or had a clinical improvement in blood
pressure on follow-up (Tables IV and V).
There was no signiﬁcant change in preintervention
mean SCr concentration (1.1 6 0.6 mg/dL) compared
Table IV. Change in blood pressure and medication
requirement
N ¼ 18
Preintervention,
mean 6 SD
Postintervention,
mean 6 SD P value
Blood
pressure,
mm Hg
166 6 22/100 6 21 133 6 16/81 6 12 .002
No. of
medications
2.3 6 1.2 1.2 6 1 .001
Table V. Blood pressure clinical response
N ¼ 18
Cure,
No (%)
Improvement,
No (%)
No improvement,
No (%)
Patients with
hypertension
5 (28) 12 (67) 1 (5)
Table VI. Preservation of renal function and renal mass
Preintervention,
mean 6 SD
Postintervention,
mean 6 SD P value
SCr,a mg/dL 1.1 6 0.6 0.9 6 0.6 .25
eGFR,a mL/min/
1.73 m2
94.6 6 45 103 6 40 .35
Renal length,b cm 10.9 6 1.3 11.3 6 1.7 .15
Cortical
thickness,b cm
1.4 6 0.4 1.4 6 0.4 .62
eGFR, Estimated glomerular ﬁltration rate; SCr, serum creatinine.
aData available for 20 patients.
bData available for 15 patients; mean follow-up, 68 months (range, 7.7-
192.7 months).
Fig 7. Survival curve by life-table methods for all patients. Stan-
dard error is <10% for all data points.
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Preintervention mean eGFR (94.6 6 45 mL/min/
1.73 m2) did not change signiﬁcantly compared with post-
intervention values (103 6 40 mL/min; P ¼ .35). On
follow-up duplex imaging, renal mass as measured bymean kidney length (11.3 cm) and cortical thickness
(1.4 cm) was preserved compared with preintervention
values (P ¼ .15 and P ¼ .62, respectively; Table VI).
There were three late deaths, none related to the renal
procedure. Two patients were conﬁrmed deceased by the
Social Security Death Index. The third patient died 8.8 years
after the index procedure from an unrelated cause. Five-
and 10-year survival was 85% and 68%, respectively (Fig 7).
DISCUSSION
This review describes surgical repair of 24 kidneys with
complex renal artery disease in 23 consecutive patients dur-
ing a 25-year period. By ex vivo cold preservation tech-
niques, complex renal artery lesions were repaired and
reconstructed safely with minimal perioperative morbidity
and no mortality. Anatomic durability was achieved with
a 5- and 10-year primary patency rate of 94%. Only one
late bypass graft occlusion occurred in a patient who under-
went repair with cephalic vein as a conduit. Ninety-four
percent of all patients with preexisting hypertension were
either cured or had statistically signiﬁcant improvement in
blood pressure and antihypertensive medication require-
ments. Furthermore, ex vivo repair of complex renal artery
lesions preserved not only renal function but renal mass as
well. On the basis of a review of the literature, this is the
ﬁrst case series of surgical renal intervention that provides
information on renal mass with morphologic parameters
obtained by ultrasonography.
Numerous experiments have demonstrated the rela-
tionship between aging and renal function and renal
mass.13-15 The normal aging process is followed by a steady
decline in renal function.13,14 Classic insulin clearance
studies by Davies and Shock15 indicated that GFR declines
by about 8 mL/min/1.73 m2 per decade starting at the
fourth decade. Moreover, renal senescence is associated
with a progressive reduction in kidney weight, with the
renal cortex being affected more than the medulla.16 The
decrease in renal mass with aging is also consistent with
thinning of the cortical ribbon and the reduction in the
number of glomeruli.17-19 Up to 10% of glomeruli may
be sclerotic in the healthy person younger than 40 years.20
The effect of various systemic diseases on the change in
renal mass is variable and depends on existing underlying
disease. Systemic diseases such as hypertension, diabetes,
and atherosclerosis are contributing factors shown to accel-
erate the steady decline in renal mass.21-23 In addition to
age and systemic factors, the loss of renal mass from renal
ischemia due to stenosis or obstruction of the main renal
artery or preglomerular arteries has been well docu-
mented.24,25 A study by Mounier-Vehier et al26 demon-
strated statistically signiﬁcant cortical thinning or atrophy
of both kidneys in predominantly young, hypertensive fe-
male patients with unilateral FMD compared with similar
control patients with essential hypertension without renal
artery disease. Although the pathophysiologic mechanism
to explain the effect of unilateral renal artery FMD on
both renal cortices is uncertain and deserves further inves-
tigation, this relationship may contribute to the overall
JOURNAL OF VASCULAR SURGERY
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renal preservation that is seen with renal revascularization
in patients with FMD.
Given the normal steady deterioration in renal function
and mass with aging and existing systemic diseases such as
hypertension and atherosclerosis, renal preservation be-
comes paramount in patients with renal artery disease,
particularly in young patients with an otherwise normal
life expectancy. Most patients included in published studies
that speciﬁcally evaluated outcomes of complex renal artery
lesions treated with surgical revascularization were young
women, in relatively good health with a normal life expec-
tancy.1-5,7,27 The demographic of this patient population
not only underscores the importance of renal preservation
during their lifetime but mandates that the surgical modal-
ity be safe, efﬁcacious, and durable. Our experience with
the ex vivo technique for complex renal artery disease meets
these requirements by demonstrating signiﬁcant improve-
ment of the hypertensive diathesis and preservation of renal
function and mass with excellent 5- and 10-year patency.
Some have recently advocated a preferential use of
endovascular repair for complex renal artery disease that
traditionally has been treated with open surgical revascular-
ization.28,29 Data have accumulated supporting acceptable
technical success and clinical outcomes with endovascular
techniques when they are applied to lesions of the main
renal artery due to atherosclerotic stenosis or FMD.30-33
These positive results have led to several case reports and
small series demonstrating technically successful treatment
of more anatomically complex lesions that involve the distal
renal artery or segmental branch vessels with catheter-
based interventions. Although it is feasible from a technical
standpoint, the results of endovascular repair for complex
renal artery lesions are subjected to postembolization syn-
drome with segmental renal ischemia, decline in renal func-
tion, subsequent nephrectomy, and uncertain long-term
durability.34-37 For instance, Zhang et al34 preferentially
treat renal artery aneurysms and renal arteriovenous ﬁstulas
with endovascular techniques as ﬁrst-line therapy. In their
larger series of 15 patients, nine renal artery aneurysms
and six renal artery arteriovenous ﬁstulas were treated by
coil embolization, stent grafting, or a combination of the
two with a technical success of 100% and no mortality or
major complications. However, 60% of patients experi-
enced postembolization syndrome. Furthermore, radio-
logic evidence of partial renal infarct was found in 33% of
patients during a mean imaging follow-up of 16 months.
During a mean clinical follow-up of 24 months, there
was no recurrence or any evidence of renal insufﬁciency
on the basis of measured SCr concentration alone. In addi-
tion, no objective data on preservation of renal mass were
reported. A more recent study of 40 patients compared
endovascular intervention with open repair of renal artery
aneurysms. During a mean follow-up of 36 months, both
groups had equivalent perioperative morbidity and mortal-
ity and similar freedom from reintervention. However, an
adjusted mixed linear analysis of the rate of GFR change
over time demonstrated a signiﬁcant decline in renalfunction (a decrease of 15 mL/min/1.73 m2 in GFR at
36 months) after endovascular intervention compared
with open repair (no decline).29 Consequently, additional
experience demonstrating that an endovascular approach
effectively preserves renal function and renal mass is
required. Until then, open ex vivo reconstruction for com-
plex renal artery disease provides a durable and effective
approach for preservation of renal function and
mass.1,2,4,5,7
There are several limitations to this study, including the
limited sample size and its retrospective nature. In addition,
the relative rarity of renal artery aneurysms and their
anatomic complexity in relation to the renal artery branch
vessels result in unavoidable selection bias. Our preference
for ex vivo renal artery reconstruction to other techniques,
including in situ repair with and without cold perfusion as
well as endovascular repair in the treatment of complex
renal artery disease, limits any deﬁnitive comparative con-
clusions between the technique and that of other institu-
tional series. Nevertheless, we believe the operative
technique detailed in our study was able to achieve salutary
outcomes in regard to mortality, blood pressure response,
renal function and mass, and durability. Our ﬁndings are
consistent with those of similar published series using the
same techniques and support selective surgical repair of
complex renal artery disease by this operative approach.
CONCLUSIONS
Complex lesions of the renal artery, particularly with
segmental branch vessel involvement, can be managed by
ex vivo reconstructive techniques with minimal periopera-
tive morbidity and mortality. This technique was found
to be anatomically durable and effective in the manage-
ment of renal artery-mediated hypertension with preserva-
tion of renal function and mass. Therefore, the ex vivo
reconstructive technique should be considered a competi-
tive alternative to other open surgical techniques for the
management of complex renal artery disease.
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Submitted Nov 5, 2013; accepted Jan 24, 2014.DISCUSSIONDr Christian de Virgilio (Torrance, Calif). First off, I want
to thank the Western Vascular Surgery Society for the opportunity
to comment on this paper. I want to congratulate Dr Ham for
an excellent presentation. Dr Ham describes surgical repair
of 24 kidneys with complex renal artery pathology in 23 consec-
utive patients over a 25-year period. Using ex vivo cold preserva-
tion techniques, complex renal artery lesions were repaired and
reconstructed safely with low perioperative morbidity and no
mortality, and an impressive 5-year primary patency rate of
94%. There was only one late bypass graft occlusion, and 94%
of patients with pre-existing HTN were either cured or had sta-
tistically signiﬁcant improvement in BP and antihypertensive
medication requirements. A unique and important aspect of
this paper, as compared to other smaller series, is the long-term
follow-up, which was a mean of 44 months, as well as the careful
documentation of not only creatinine, but also creatinineclearance, kidney length, and cortical thickness. I would challenge
those who attempt these complex aneurysms via an endovascular
approach to provide similar meticulous follow-up. TheUSC group
should be commended for excellent outcomes. I had several
questions:
1) You mentioned in the manuscript that you utilized routine intra-
operative completion duplex scan to assess the adequacy of the
repair. What criteria did you use? And, what was your approach
when you detected a signiﬁcant lesion intraoperatively?
2) Though it was only one case, would you use cephalic vein
again?
3) Recently, there have been a few cases series utilizing laparo-
scopic nephrectomy with ex vivo repair and pelvic reimplanta-
tion for RAAA. Can you comment on the laparoscopic
approach?
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Volume 60, Number 1 Ham and Weaver 1514) Given that the experience has spanned 25 years, has your pa-
tient selection and operative technique evolved over that time,
and if so, how?
5) It is unclear from the manuscript how many of the renal artery
aneurysms were asymptomatic, and what size they were. What
size criterion do you utilize to operate on an asymptomatic
RAA? And, will that size cutoff change 15 minutes from now?
Dr Sung Wan Ham. Thank you, Dr de Virgilio, for your
comments and kind words. To address your ﬁrst question
regarding the use of intraoperative duplex to assess the adequacy
of repair, we look for velocity shifts and color-ﬂow disturbances
across the arterial anastomosis as well as inspecting ﬂow in the renal
vein. A decision to revise one or more anastomoses is dependent
on all these factors. In general, anastomoses with velocity shifts
of 3:1 or greater that are associated with a B mode defect and co-
lor-ﬂow disturbance would be candidates for revision. The decision
to reinstitute cold perfusion is made if revision is anticipated to
exceed 30 minutes.
Regarding your second question, our experience with cephalic
vein as renal artery conduit reminds us why the cardiac surgeons
stopped using them for coronary artery bypasses. The profound
intimal hyperplastic reaction we observed in a relatively short
period of time was likely due to the high-ﬂow rates that are seen
in the aortorenal position. Therefore, in the future, we will likely
use prosthetic over cephalic vein for aortorenal bypasses in patients
with no suitable saphenous vein.
As to your third question, there have been a few case reports
and small series successfully utilizing laparoscopic nephrectomy
modeled after live-donor transplant techniques with back bench
ex vivo reconstruction and heterotopic reimplantation in to the
pelvis. Claimed advantages of this technique include smaller inci-
sional morbidity and optimal surgical visualization at the back table
allowing meticulous dissection and complex reconstruction of
branch vessels. Other theoretic advantages include quicker recov-
ery and technically easier access for duplex surveillance. However,
compared to replacement of the kidney back into the renal fossa,the advantages of laparoscopic nephrectomy and pelvic autotrans-
plantation must be traded for an additional anastomosis between
the ureter and bladder and its associated complications of leak or
stricture formation. Furthermore, although there is nothing inher-
ently wrong with using the iliac vessels as arterial inﬂow, given the
relatively young age of the patients in our cohort, who had a mean
age of 45 years old, theoretical progression of atherosclerotic
occlusive disease of the iliac vessels over the remainder of their life-
time may compromise the renal reconstruction. Since the major
advantage of ex vivo reconstruction is the extended cold ischemia
time, which allows for precise branch vessel reconstruction, we
preferentially replace the kidney in its orthotopic position with
use of standard aortic attachment sites.
Regarding the question about our patient selection and oper-
ative techniques over time, our patient selection has been rather
constant over the years. Although more sophisticated catheter-
based techniques are now available to address these lesions, we
feel that open repair provides the best chance for renal preservation
in the long term. That is why we have not extended the indication
for repair to endovascular techniques in this highly select group of
patients. Over the past 25 years, there have been no major modi-
ﬁcations to our operative techniques. Our preference for replace-
ment of the reconstructed kidney to its original position in the
renal fossa over autotransplantation in to the pelvis was adopted
early on in our experience and has not changed over time.
As to you your last question, of the 24 renal arteries treated,
19 (79%) were aneurysmal. Of the 19 renal artery aneurysms,
eight (42%) of them were asymptomatic. The average size of
asymptomatic renal artery aneurysms was 1.9 cm and 2.9 cm
for symptomatic aneurysms. All patients who had asymptomatic
aneurysms were also hypertensive. Generally speaking, our indica-
tions for renal artery aneurysm repair are tailored to individual pa-
tient presentation, with surgical repair reserved for asymptomatic
aneurysms >2 cm in size and those in women of child bearing
age. That said, all patients in our series with asymptomatic aneu-
rysms had a mean aneurysm size of only 1.9 cm but had another
indication for surgery.
